This inventor holds 1 USPTO granted patent. Top assignee: Serum Institute of India Private Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Adar Cyrus Poonawalla: Innovator in Vaccine Development
Introduction
Adar Cyrus Poonawalla is a prominent inventor based in Pune, Maharashtra, India. He is known for his significant contributions to the field of vaccine development. His innovative work has led to advancements in immunogenic compositions that are crucial for public health.
Latest Patents
Poonawalla holds a patent for "Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof." This patent describes stable lyophilized immunogenic compositions that include live attenuated recombinant flaviviruses, particularly dengue viruses. The composition is designed to preserve the virus's viability, immunogenicity, and stability without the use of preservatives, polymers, or surfactants. The methods for manufacturing these stable compositions are also detailed in the patent. He has 1 patent to his name.
Career Highlights
Adar Poonawalla is associated with the Serum Institute of India Private Limited, a leading biotechnology company. His work at the institute has been instrumental in developing vaccines that address various infectious diseases. His expertise in vaccine formulation and stability has made him a key figure in the industry.
Collaborations
Poonawalla has collaborated with notable colleagues such as Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. These collaborations have further enhanced the research and development efforts at the Serum Institute of India.
Conclusion
Adar Cyrus Poonawalla's contributions to vaccine innovation are noteworthy and have a lasting impact on public health. His work exemplifies the importance of research and development in combating infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile